(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.)
* Futures down: Dow 0.9%, S&P 1%, Nasdaq 1%
By Shriya Ramakrishnan
Dec 11 (Reuters) - U.S. stock index futures fell 1% on Friday as delays over a new fiscal stimulus package and surging coronavirus infections dented sentiment even as regulators moved toward emergency use authorization of a COVID-19 vaccine.
With fresh business restrictions in many states and a jump in weekly jobless claims, investors are counting on more fiscal relief to sustain a nascent economic recovery.
But an agreement remains elusive and House Speaker Nancy Pelosi on Thursday raised the possibility of negotiations dragging on through Christmas. stocks, which stand to benefit from an economic recovery, led declines in premarket trading on Friday, with energy, industrial and financial sectors all lower.
Major banks Wells Fargo (NYSE: WFC ) & Co WFC.N and JPMorgan Chase & Co (NYSE: JPM ) JPM.N slid more than 1%, while industrial bellwethers Boeing (NYSE: BA ) Co BA.N and 3M (NYSE: MMM ) Co MMM.N fell 1.6% and 0.9%, respectively.
At 06:29 a.m. ET, Dow E-minis 1YMcv1 were down 270 points, or 0.89%, S&P 500 E-minis EScv1 were down 37.5 points, or 1.02%, and Nasdaq 100 E-minis NQcv1 were down 125.75 points, or 0.98%.
Global stock markets were also subdued after scaling record highs earlier this week as the UK became the first country in the world to begin a mass COVID-19 vaccination program. MKTS/GLOB
A panel of outside advisers to the U.S. Food and Drug Administration on Thursday voted overwhelmingly to endorse emergency use of Pfizer (NYSE: PFE )'s PFE.N COVID-19 vaccine, sending shares of the drugmaker up 1.9% in premarket trading. MA.N dropped 1.4% after the UK Supreme Court gave the green light for a $18.5 billion class action against the company for allegedly overcharging more than 46 million people in Britain over a 15-year period.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.